shutterstock_2183917051_t-schneider
T. Schneider / Shutterstock.com
28 November 2022AmericasStaff Writer

USITC launches drug research patents probe

German biopharma company’s complaint against Palo Alto competitor prompts commission to investigate | Patents in dispute relate to bio-layer interferometry.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

article
3 May 2022   The US International Trade Commission has agreed to investigate imports of botulinum toxin products following a complaint that they infringe trade secrets.
Americas
19 January 2021   The US International Trade Commission is to investigate allegations that a Chinese company infringed patents held by Ventria Bioscience by importing genetically-engineered rice seeds for medical purposes.

More on this story

article
3 May 2022   The US International Trade Commission has agreed to investigate imports of botulinum toxin products following a complaint that they infringe trade secrets.
Americas
19 January 2021   The US International Trade Commission is to investigate allegations that a Chinese company infringed patents held by Ventria Bioscience by importing genetically-engineered rice seeds for medical purposes.

More on this story

article
3 May 2022   The US International Trade Commission has agreed to investigate imports of botulinum toxin products following a complaint that they infringe trade secrets.
Americas
19 January 2021   The US International Trade Commission is to investigate allegations that a Chinese company infringed patents held by Ventria Bioscience by importing genetically-engineered rice seeds for medical purposes.